article_metadata: Atsushi Kohso Hidemi Toyoda Ryo Hanaki Kaori Niwa Yosuke Okumura Mari Morimoto Takahiro Ito Masahiro Hirayama
article_metadata: 10.1007/s12185-024-03890-1
article_metadata: Int J Hematol
article_metadata: 2025 Feb;121(2):276-280.
article_metadata: b-cell precursor acute lymphoblastic leukemia inotuzumab ozogamicin maintenance chemotherapy relapse
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39648271/
article_metadata: Down Syndrome / complications Inotuzumab Ozogamicin Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Recurrence
article_metadata: Down Syndrome / complications Inotuzumab Ozogamicin Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Recurrence Case Reports Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / adverse effects Antineoplastic Agents, Immunological / therapeutic use Child Hematopoietic Stem Cell Transplantation Humans Male Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy Remission Induction Secondary Prevention Inotuzumab Ozogamicin Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological
article_metadata: PMC11782362
article_metadata: 39648271
article_metadata: Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia
article_metadata: 2025